ABPI Logo
  • Developing medicines
    • Responding to COVID-19
    • Clinical trials and research
    • Building a thriving environment for medicine discovery
    • UK-EU Future Relationship
    • Life Sciences Industrial Strategy
    • ABPI Medical Representatives Exam
  • Accessing medicines
    • How medicines are priced in the UK
    • Working with the NHS
    • Supply chain
    • Antimicrobial resistance (AMR)
    • Vaccines
    • What is the NICE Methods Review?
    • Rare diseases: Facing three challenges
  • Our ethics
    • ABPI Code of Practice
    • Disclosure UK
    • Appropriate prescribing
    • Patient & public involvement
  • Member representation
    • Events
    • Full membership
    • Working with our members​
    • ABPI Members List
    • Membership benefits
  • Who We Are
  • Media
  • Publications
  • Facts and Figures
  • Contact Us
MY ABPI LOGIN
 
  • The Association of the British Pharmaceutical Industry
  • Facts and figures
  • Clinical trial data
  • Number of commercial clinical trials started by country, Phase I (2012-2018)

Number of commercial clinical trials started by country, Phase I (2012-2018)

Figure 4. Number of commercial clinical trials started by country, Phase I (2012-2018)

Figure 4. Number of commercial clinical trials started by country, Phase I (2012-2018)

 

 

Clinical trial data

  • Number of commercial clinical trials started in the UK, by year and phase (2012-2018)
  • Number of commercial clinical trial applications received by MHRA, by year (2013-2018)
  • Number of clinical trial applications received by MHRA in 2018, by phase and sponsor type
  • Number of commercial clinical trials started by country, Phase I (2012-2018)
  • Number of commercial clinical trials started by country, Phase II (2012-2018)
  • Number of commercial clinical trials started by country, Phase III (2012-2018)
  • Number of commercial clinical trials started in the UK, by year and disease area (2012-2018)
  • Number of commercial clinical trials started in oncology, by year and country (2012-2018)
  • Number of commercial clinical trials started in cardio-metabolic diseases, by year and country (2012-2018)
  • Number of commercial clinical trials started in nervous system diseases, by year and country (2012-2018)
  • Number of commercial clinical trials started in immune disorders, by year and country (2012-2018)
  • Number of commercial clinical trials started in infectious diseases, by year and country (2012-2018)

ABPI

The Association of the British Pharmaceutical Industry is a company limited by guarantee registered in England and Wales 
(registered number 09826787) and its registered office is at 7th Floor Southside,105 Victoria Street, London, SW1E 6QT.
Telephone +44 (0) 207 9303477

© ABPI 2021
  • Twitter Logo
  • LinkedIn
  • YouTube Logo

Devolved Nations

  • Cymru Wales
  • Northern Ireland
  • Scotland

Quick Links

  • ABPI Exam
  • Disclosure UK
  • Frequently Asked Questions
  • Careers
  • Schools
  • Acronym buster

Website Info

  • Terms and conditions
  • Accessibility
  • Cookie Policy

Prescription Medicines Code of Practice Authority (PMCPA)

The Prescription Medicines Code of Practice Authority (PMCPA) was established by The Association of the British Pharmaceutical Industry to operate the ABPI Code of Practice for the Pharmaceutical Industry independently of the ABPI. The PMCPA is a division of ABPI which is a company registered in England and Wales (registered number 09826787) with its registered office at 7th Floor, Southside, 105 Victoria Street, London SW1E 6QT.

Office of Health Economics (OHE)

The Office of Health Economics (OHE) is a company limited by guarantee registered in England and Wales (registered number 09848965) and its registered office is at 7th Floor Southside, 105 Victoria Street, London, SW1E 6QT. OHE provides independent research, advisory and consultancy services on policy implications and economic issues within the pharmaceutical, health care and biotechnology sectors.